ResMed Inc (RMD)
243.63
+2.08
(+0.86%)
USD |
NYSE |
Nov 21, 16:00
244.95
+1.32
(+0.54%)
After-Hours: 20:00
ResMed Price to Book Value: 6.884 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.826 |
| November 19, 2024 | 6.729 |
| November 18, 2024 | 6.765 |
| November 15, 2024 | 6.633 |
| November 14, 2024 | 6.540 |
| November 13, 2024 | 6.653 |
| November 12, 2024 | 6.985 |
| November 11, 2024 | 7.027 |
| November 08, 2024 | 7.132 |
| November 07, 2024 | 7.023 |
| November 06, 2024 | 6.941 |
| November 05, 2024 | 6.944 |
| November 04, 2024 | 6.884 |
| November 01, 2024 | 6.903 |
| October 31, 2024 | 6.852 |
| October 30, 2024 | 6.867 |
| October 29, 2024 | 6.906 |
| October 28, 2024 | 6.975 |
| October 25, 2024 | 7.236 |
| October 24, 2024 | 6.755 |
| October 23, 2024 | 6.708 |
| October 22, 2024 | 6.781 |
| October 21, 2024 | 6.783 |
| October 18, 2024 | 6.781 |
| October 17, 2024 | 6.769 |
| Date | Value |
|---|---|
| October 16, 2024 | 6.734 |
| October 15, 2024 | 6.758 |
| October 14, 2024 | 6.801 |
| October 11, 2024 | 6.795 |
| October 10, 2024 | 6.722 |
| October 09, 2024 | 6.697 |
| October 08, 2024 | 6.670 |
| October 07, 2024 | 6.563 |
| October 04, 2024 | 6.611 |
| October 03, 2024 | 6.736 |
| October 02, 2024 | 6.749 |
| October 01, 2024 | 6.746 |
| September 30, 2024 | 6.897 |
| September 27, 2024 | 7.212 |
| September 26, 2024 | 7.319 |
| September 25, 2024 | 7.264 |
| September 24, 2024 | 7.457 |
| September 23, 2024 | 7.437 |
| September 20, 2024 | 7.399 |
| September 19, 2024 | 7.340 |
| September 18, 2024 | 7.190 |
| September 17, 2024 | 7.578 |
| September 16, 2024 | 7.605 |
| September 13, 2024 | 7.520 |
| September 12, 2024 | 7.573 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.660
Minimum
Oct 27 2023
15.01
Maximum
Sep 08 2021
9.306
Average
9.621
Median
Price to Book Value Benchmarks
| Boston Scientific Corp | 6.512 |
| Globus Medical Inc | 2.840 |
| Abbott Laboratories | 5.111 |
| Haemonetics Corp | 4.884 |
| Becton Dickinson & Co | 2.515 |
Price to Book Value Related Metrics
| PE Ratio | 32.27 |
| PS Ratio | 7.477 |
| PEG Ratio | 1.430 |
| Price to Free Cash Flow | 26.69 |
| Price | 243.63 |
| Earnings Yield | 3.10% |
| Market Cap | 35.76B |
| PEGY Ratio | 1.379 |
| Operating PE Ratio | 24.25 |
| Normalized PE Ratio | 30.74 |